RecruitingRecruiting
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
NCT05414409 · Indiana University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin
About this study
Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for complications. The proposed study is relevant to public health because it helps us understand the role of the gut microbiome in disease pathophysiology in T1D youth with overweight and obesity as well as potential mechanisms to modify disease.
Eligibility criteria
Inclusion Criteria:
1. Overweight/obese youth 11-18 years of age with T1D at time of enrollment.
2. Lean youth 11-18 years of age with T1D at time of enrollment.
Exclusion Criteria:
1. Known monogenic forms of diabetes or Type 2 diabetes (confirmed clinically and by genetic/antibody testing).
2. History of ongoing infection or antibiotic treatment within the past month;
3. History of immune-compromise, recurrent infections, steroid intake (inhaled or oral forms) or other immunosuppressant use in the past 6 months.
4. History of chronic gastrointestinal disease and active within the past 6 months, possible or confirmed celiac disease.
5. Participation in any research intervention trials within the past 3 months.
6. History of treatment or use of metformin, a type 2 diabetes medication.
Study design
Enrollment target: 114 participants
Allocation: non_randomized
Masking: none
Age groups: child, adult
Timeline
Starts: 2022-09-30
Estimated completion: 2027-03-01
Last updated: 2026-08-21
Interventions
Drug: Metformin
Primary outcomes
- • Differences in the gut microbiome in lean and overweight/obese youth with type 1 diabetes (Baseline)
- • Differences in the gut microbial metabolites in lean and overweight/obese youth with type 1 diabetes (Baseline)
- • Differences in the gut microbial metabolites in lean and overweight/obese youth with type 1 diabetes (Baseline)
Sponsor
Heba M. Ismail · other
With: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contacts & investigators
ContactHeba M Ismail · contact · heismail@iu.edu · 317-274-2114
ContactHI Team · contact · hiteam@iu.edu · 317-274-2114
All locations (1)
Indiana University School of MedicineRecruiting
Indianapolis, Indiana, United States